Study: There are major risks to taking niacin for cholesterol issues


More than 700,000 prescriptions are written for niacin each month in the United States, but a new study finds that the pills might do more harm than good.
Niacin is a B vitamin, and is often given to patients who need to lower their "bad" cholesterol while raising the "good" kind. Researchers at Oxford University studied more than 25,000 people in Europe and China who took niacin while undergoing standard cholesterol treatment. The "bad" cholesterol (LDL) did decrease, but the niacin was also linked to a 32 percent increase in diabetes over four years. There were other side effects, like bleeding, heartburn, and stomach ulcers, and taking niacin didn't seem to lower rates of chest pain, stroke, or heart attack.
"On the basis of the weight of available evidence showing net clinical harm, niacin must be considered to have an unacceptable toxicity profile for the majority of patients, and it should not be used routinely," Dr. Donald Lloyd-Hones of Northwestern University's Feinberg School of Medicine wrote in a commentary. The Mayo Clinic still recommends taking niacin, but only after consulting with a doctor.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
The report was published Wednesday in the New England Journal of Medicine.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Catherine Garcia has worked as a senior writer at The Week since 2014. Her writing and reporting have appeared in Entertainment Weekly, The New York Times, Wirecutter, NBC News and "The Book of Jezebel," among others. She's a graduate of the University of Redlands and the Columbia University Graduate School of Journalism.
-
Is China winning the AI race?
Today's Big Question Or is it playing a different game than the US?
-
5 refreshing podcasts you may have missed this spring
The Week Recommends Exploring the cultural impact of Jerry Springer, a look at contemporary spending habits and more
-
Mortgages: The future of Fannie and Freddie
Feature Donald Trump wants to privatize two major mortgage companies, which could make mortgages more expensive
-
RFK Jr. scraps Covid shots for pregnant women, kids
Speed Read The Health Secretary announced a policy change without informing CDC officials
-
New FDA chiefs limit Covid-19 shots to elderly, sick
speed read The FDA set stricter approval standards for booster shots
-
US overdose deaths plunged 27% last year
speed read Drug overdose still 'remains the leading cause of death for Americans aged 18-44,' said the CDC
-
Trump seeks to cut drug prices via executive order
speed read The president's order tells pharmaceutical companies to lower prescription drug prices, but it will likely be thrown out by the courts
-
RFK Jr. visits Texas as 2nd child dies from measles
Speed Read An outbreak of the vaccine-preventable disease continues to grow following a decade of no recorded US measles deaths
-
Shingles vaccine cuts dementia risk, study finds
Speed Read Getting vaccinated appears to significantly reduce the chances of developing Alzheimer's and other forms of dementia
-
Measles outbreak spreads, as does RFK Jr.'s influence
Speed Read The outbreak centered in Texas has grown to at least three states and Health Secretary Robert F. Kennedy Jr. is promoting unproven treatments
-
RFK Jr. offers alternative remedies as measles spreads
Speed Read Health secretary Robert F. Kennedy Jr. makes unsupported claims about containing the spread as vaccine skepticism grows